<p>Genes alterations Related to Hypertrophic/Dilated Cardiomyopathy in VIP<sup>−/−</sup> mice compared to WT mice.</p
Cardiac hypertrophy is a condition in which enlargement of the heart that can be physiological or pa...
<p>The list of gene sets down-regulated in heart tissue from SHP KO HFD mice compared to that from W...
Cardiac hypertrophy is an important risk factor for cardiac morbidity and mortality. To unravel the ...
<p>Gene expression alterations in VIP<sup>−/−</sup> mice compared to WT mice.</p
) develop both right (RV) and left ventricular (LV) cardiomyopathy, manifested by LV dilatation and ...
Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant disease characterized by left ve...
RATIONALE: Vasoactive Intestinal Peptide (VIP), a pulmonary vasodilator and inhibitor of vascular sm...
A mouse model of hypertrophic cardiomyopathy (HCM) was created by expression of a cardiac alpha-myos...
Abstract Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity. We investig...
Familial hypertrophic cardiomyopathy (HCM) is attributed to mutations in genes that encode for the s...
Familial hypertrophic cardiomyopathy (HCM) is attributed to mutations in genes that encode for the s...
A traditional approach to investigate the genetic basis of complex diseases is to identify genes wit...
<p>(A) Typical H & E staining pictures of mouse heart tissue sections. (B) The mean cross sectional ...
<p>A. Low-power magnifications of Masson Trichrome stained images of the left ventricle of WT and α-...
AbstractCardiac hypertrophy is an important risk factor for cardiac morbidity and mortality. To unra...
Cardiac hypertrophy is a condition in which enlargement of the heart that can be physiological or pa...
<p>The list of gene sets down-regulated in heart tissue from SHP KO HFD mice compared to that from W...
Cardiac hypertrophy is an important risk factor for cardiac morbidity and mortality. To unravel the ...
<p>Gene expression alterations in VIP<sup>−/−</sup> mice compared to WT mice.</p
) develop both right (RV) and left ventricular (LV) cardiomyopathy, manifested by LV dilatation and ...
Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant disease characterized by left ve...
RATIONALE: Vasoactive Intestinal Peptide (VIP), a pulmonary vasodilator and inhibitor of vascular sm...
A mouse model of hypertrophic cardiomyopathy (HCM) was created by expression of a cardiac alpha-myos...
Abstract Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity. We investig...
Familial hypertrophic cardiomyopathy (HCM) is attributed to mutations in genes that encode for the s...
Familial hypertrophic cardiomyopathy (HCM) is attributed to mutations in genes that encode for the s...
A traditional approach to investigate the genetic basis of complex diseases is to identify genes wit...
<p>(A) Typical H & E staining pictures of mouse heart tissue sections. (B) The mean cross sectional ...
<p>A. Low-power magnifications of Masson Trichrome stained images of the left ventricle of WT and α-...
AbstractCardiac hypertrophy is an important risk factor for cardiac morbidity and mortality. To unra...
Cardiac hypertrophy is a condition in which enlargement of the heart that can be physiological or pa...
<p>The list of gene sets down-regulated in heart tissue from SHP KO HFD mice compared to that from W...
Cardiac hypertrophy is an important risk factor for cardiac morbidity and mortality. To unravel the ...
DOI
Add to ORKG